I Mab Appoints Sean (Xi Yong) Fu, Ph D, Mba As Chief Executive Officer

Nov 06, 2024•9 months ago

Position

Chief Executive Officer

Company

I-Mab Biopharma

Sean (Xi-Yong) Fu

RockvilleBiotechnology

Description

I-Mab announced the appointment of Sean (Xi-Yong) Fu, PhD, MBA as the permanent Chief Executive Officer (CEO) effective November 1, 2024. Dr. Fu has over 20 years of industry experience in the life sciences industry, leading and developing clinical-stage assets.

Company Information

Company

I-Mab Biopharma

Location

Rockville, Maryland, United States

About

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in the U.S. in Rockville, Maryland, and in Short Hills, New Jersey.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months